Sunday, Feb 02

The FDA has approved Journavx, a new non-opioid pain medication, aiming to combat opioid addiction and overdose risks in patients.

Friday, Jan 31

The FDA has approved Journavx, a groundbreaking non-opioid painkiller, marking the first new class in over 20 years, aiming to eliminate the risks of opioid addiction.

Friday, Jan 24

The Trump administration has frozen federal health agency communications pending political review, raising public safety concerns about timely health information.

Thursday, Jan 23

The Trump administration has halted federal health agency communications, prompting concerns over public safety and timely disease updates.

Saturday, Jan 18

Robert F. Kennedy Jr. called for revoking COVID vaccine authorization six months post-rollout, citing concerns over safety amid the pandemic.

Friday, Jan 17

A Texas judge permits Idaho, Kansas, and Missouri to challenge federal access to mifepristone, impacting abortion rights across the U.S.

Friday, Jan 17

The FDA has authorized Zyn nicotine pouches for sale, highlighting their potential as a safer alternative for adult smokers looking to quit.

Friday, Jan 17

The FDA has banned Red Dye No. 3 in food and drugs due to cancer risks. Discover what's affected and the alternatives for this widely-used food additive.

Thursday, Jan 16

The FDA has officially banned Red Dye No. 3 from food and beverages due to cancer risks linked to animal studies, marking a significant regulatory change.

Wednesday, Jan 15

The FDA proposes to cap nicotine in cigarettes to combat addiction and promote public health reforms. Public comments are welcomed on this crucial measure.